Navigation Links
Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies
Date:6/10/2013

CARLSBAD, Calif. and VANCOUVER, British Columbia, June 10, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) and Xenon Pharmaceuticals Inc. announced today that Xenon has exercised its option  to an exclusive worldwide license to XEN701, an antisense drug discovered in a collaboration between Isis and Xenon.  For the license of XEN701, Isis earns a $2 million payment from Xenon.  XEN701 is a drug candidate designed to inhibit the production of hepcidin, a target Xenon identified utilizing its extreme genetics platform for the treatment of anemia of chronic disorders (ACD).  XEN701 is currently being evaluated in studies to support clinical development.  Xenon plans to initially develop XEN701 for patients with chronic kidney disease who are intolerant of or who are poor responders to erythropoietin (Epo) therapy. XEN701 is the first drug to enter development from Isis' collaboration with Xenon.

"We are delighted with the advances we have made with Isis to discover XEN701," said Simon Pimstone, Xenon's President and CEO. "XEN701 has the potential to provide significant therapeutic benefit to patients with ACD through a novel non-Epo receptor based mechanism and we are looking forward to initiating clinic studies with this compound."

"We are pleased with the success of our collaboration with Xenon and the opportunity to apply our antisense drug discovery technology to discover XEN701, a novel antisense drug to treat ACD," said B. Lynne Parshall, chief operating officer at Isis.  "A key component of our business strategy is to exploit the broad applicability of our antisense technology platform in order to develop antisense drugs in many different therapeutic areas.  By working with partners like Xenon, who are highl
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Xenon Announces Appointment of EVP, Research & Development
2. Xenon Named Life Sciences Company of the Year by LifeSciences British Columbia
3. Xenon Exclusively Licenses to Merck Compounds for a Novel Target for Cardiovascular Disease
4. MetaStat, Inc. Executes Two New Licenses
5. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
6. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
7. NTT DATA Licenses DATATRAK ONE™ for China
8. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
9. West Health Institute licenses Kinect-based physical therapy technology to Reflexion Health; West Health Investment Fund makes $4.25 million investment
10. Parios Regenerative Sciences, Inc. Licenses Exclusive Rights to Organic Nanotechnology for Skin Repair
11. uniQure Licenses RNA Interference Technology to Advance Huntingtons Disease Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015 BioRx, a Diplomat ... recognized as a Top Workplace in 2015 based on a ... the Enquirer Media Group and a Philadelphia ... 22 questions and was completed by employees across the ... area, with topics ranging from workplace environment to ...
(Date:7/7/2015)... NEW YORK , July 7, 2015 /PRNewswire/ ... Welch Allyn for $2 billion in cash and ... competitive patient monitoring market, according to Kalorama Information. ... heretofore participated in the medical device and advanced ... maker of hospital beds, patient lifting devices, and ...
(Date:7/7/2015)... 7, 2015   ICD-10 Charts ( www.icd10charts.com ... development, it has officially launched its newest line ... Academy and the new 4 Step ICD-10 Implementation ... all other ICD-10 Charts resources and mobile apps, ... completely free-of-charge.  With the release of these resources, ...
Breaking Medicine Technology:BioRx Named a Top Workplace in 2015 by Enquirer Media 2BioRx Named a Top Workplace in 2015 by Enquirer Media 3Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 2Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 2ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 4
... Varian Medical Systems (NYSE: VAR ) is ... at 9:30 a.m. ET on Wednesday, November 17th at ... Participating executives will include Elisha Finney, senior vice ... investor relations and corporate communications. The presentation will focus ...
... GREENSBORO, N.C., Nov. 5, 2010 Merz Pharmaceuticals announced ... Xeomin® (incobotulinumtoxinA), a botulinum toxin type A free from ... Assembly of the American Academy of Physical Medicine and ... U.S. Food and Drug Administration (FDA) approved XEOMIN on ...
Cached Medicine Technology:Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation 2Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation 3Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation 4Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation 5Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation 6
(Date:7/7/2015)... ... July 07, 2015 , ... Difass USA, a modern ... pass those long, stressful days at work is knowing that there is hopefully a ... back and stress free as imagined. Planning for a vacation can be quite stressful, ...
(Date:7/7/2015)... ... , ... The United States Centers for Disease Control and Prevention have awarded ... Multicultural AIDS Coalition $3.78 million for a five-year HIV prevention partnership that will ... transgender women, the groups at highest risk of HIV infection in the US. ...
(Date:7/7/2015)... MD (PRWEB) , ... July 07, 2015 , ... SC&H ... of Service, which aims to give back to the community through company-wide volunteering efforts. ... from SC&H Group dedicate the day to assisting those in need throughout Baltimore and ...
(Date:7/7/2015)... ... July 07, 2015 , ... The Immune Deficiency Foundation ... patient community using its IDF ePHR, an electronic personal health record powered by ... to easily track their health information, including symptoms, diagnoses, medications, infusions and other ...
(Date:7/7/2015)... ... July 07, 2015 , ... FSAstore.com today announced the launch ... holders. HSAstore.com makes it simple to use, spend and manage HSA funds with innovative ... accounts. , According to a report by Devenir , approximately 13.8 million ...
Breaking Medicine News(10 mins):Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:SC&H Group Celebrates 9th Annual Day of Service 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3
... stem cells, which may provide a treatment for tumors ... pancreatic cancer, according to new research from Memorial Sloan-Kettering ... important since pancreatic cancer has a poor prognosis and ... Investigators led by Joyce Wong, MD, surgical researcher ...
... , NEW YORK (May 6, 2011) -- Among ... meeting are physician-scientists from NewYork-Presbyterian Hospital/Columbia University Medical ... McCormick Place, Chicago. The following are two notable ... A gastroenterologist at NewYork-Presbyterian Hospital/Columbia University Medical Center ...
... gene expression of their lungs similar to that suffered by ... is the conclusion of a new study, led by Catalan ... causing these alterations. "Our objective was to analyse the ... samples of patients with COPD, whether smokers or not, and ...
... up to a year before a patient is diagnosed with ... often mistaken for other diseases. However, with this blood-based test, ... disease or not", says Christer Wingren, associate professor in Immunotechnology ... determine how far the disease has progressed. There are three ...
... post-mortem tissue archive for a study of the human form ... by coroners to participate. The Coroners, Society of England and ... public health" from potential new risks associated with variant Creutzfeldt-Jakob ... of tissue from autopsies. That is the conclusion of a ...
... (HealthDay News) -- Children conceived in winter seem to have ... study suggests. Environmental factors -- including exposure to seasonal ... play a role in the greater risk for autism among ... California, Davis researchers. The investigators analyzed data from 6.6 ...
Cached Medicine News:Health News:Oncolytic viruses effectively target and kill pancreatic cancer stem cells 2Health News:NY Presbyterian/Columbia research presented at Digestive Disease Week meeting 2Health News:Smokers undergo the same changes in gene expression as patients with COPD 2Health News:New test could give SLE patients a more tolerable life 2Health News:Coroners wrong to say no to post-mortem tissue collection, academics argue 2Health News:Winter Conception Tied to Raised Risk for Autism 2
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: